NPPES file of Aug 9, 2026

William D. Mcintyre, Jr., M.D.

Hematology & Oncology Physician · Pasadena, CA

William D. Mcintyre, Jr., M.D. is a hematology & oncology physician with a practice address in Pasadena, California, and NPI 1710925144, issued on Jun 4, 2006. Check the license (California G29828, as entered in NPPES) on the Medical Board of California; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1710925144
Name
William D. Mcintyre, Jr.
Credential
M.D.
Primary taxonomy
Hematology & Oncology Physician 207RH0003X
License number
G29828 CA
Self-reported in NPPES; status is on the state search
Practice location
401 S Fair Oaks Ave, Pasadena, CA 91105
Phone
(626) 304-4400
Enumerated
Jun 4, 2006
Record last updated
Nov 7, 2024
Fax
(626) 296-3457
Medicare enrollment
Enrolled (PECOS I20110802000198); may accept Medicare assignment
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 401 S Fair Oaks Ave

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Timothy Ballard, M.D.Emergency Medicine Physician1710090816
  2. Randy Debber, PA-CMedical Physician Assistant1679627103
  3. Mark Hoffman, M.D.Internal Medicine Physician1902860109
  4. Precioustoni JacksonClinical Social Worker1790250116
  5. Lu Jiao, MDInternal Medicine Physician1023162187
  6. Phillip Lee, M.D.Dermatology Physician1578628731

Verify William D. Mcintyre, Jr. in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersMedical Board of California
    Search for license G29828
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the California license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

3.0 times the Medicare Part D claims of the average hematology & oncology physician in 2024

2,588 Medicare Part D claims for 203 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. 69 claims were for opioids.

  1. William Mcintyre, Jr.2,588
  2. Specialty average877

Most prescribed

  1. Rosuvastatin Calcium233 claims
  2. Amlodipine Besylate181 claims
  3. Atorvastatin Calcium114 claims
  4. Lisinopril87 claims
  5. Levothyroxine Sodium78 claims
  6. Nifedipine Er77 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

Industry payments in 2024: $62.02

3 payments; by number, the most common kind was food and beverage; the largest payer was Pfizer Inc. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. William Mcintyre, Jr.$62.02
  2. Specialty average$7,481.41

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Hematology & Oncology Physician providers in California

There are 1,583 hematology & oncology physician records in California.

Other hematology & oncology physician records in California

  1. Mark Abate, M.D.Santa Barbara, CA1588778674
  2. Iman Abdalla, MDLos Angeles, CA1730248311
  3. Haifaa Abdulhaq, MDFresno, CA1508024647
  4. Nihal Abdulla, MDLos Alamitos, CA1750585345
  5. Mehrad Abedi, M.D.Sacramento, CA1467459222
  6. Oyewale Abidoye, M.D.La Jolla, CA1790841815
  7. Mohammed Abu Zaanona, MDSanta Barbara, CA1922591197
  8. Mohamad Adada, M.D., PHDRoseville, CA1528590734
  9. Jesse Adams, MDSacramento, CA1851479554
  10. Thompson Adams, MDSanta Monica, CA1407880891

Common questions

What is William D. Mcintyre, Jr., M.D.'s NPI number?

William D. Mcintyre, Jr., M.D.'s National Provider Identifier (NPI) is 1710925144, issued on Jun 4, 2006. An NPI identifies a provider in billing; it is not a license.

Where is William D. Mcintyre, Jr., M.D. located?

The NPPES record lists a practice address at 401 S Fair Oaks Ave, Pasadena, CA, 91105. Phone: (626) 304-4400. Providers update this record themselves, so call before visiting.

How can I verify William D. Mcintyre, Jr., M.D.'s license?

NPPES lists California license number G29828, as entered by the provider. Search the Medical Board of California at https://www.mbc.ca.gov/License-Verification/default.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does William D. Mcintyre, Jr., M.D. prescribe under Medicare Part D?

In 2024, William D. Mcintyre, Jr., M.D. had 2,588 Medicare Part D claims for 203 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.